… of inhaled β-agonist therapy were helpful in predicting when the cough was due to asthma.
… and selfassessment of cough severity using a visual analog scale, subjects were randomized …

… fenoterol was associated with a 5-fold increase in the risk of exacerbation. After adjustment
… in risk. There was no excess risk of asthma exacerbation associated with inhaled albuterol. …

… The use of all inhaled corticosteroids and inhaled long-acting bronchodilators was
discontinued at least 48 h before study entry, although other COPD medications such as …

… nebulized bronchodilators, antibiotics, and oxygen. At day 5, FEV 1 measured after
bronchodilation … Patients should also receive antibiotics and bronchodilators. Systemic …

… of TT being more effective in reducing exacerbation risk than DB, which became more …
inhaled bronchodilators, either long-acting muscarinic antagonists (LAMAs) or long-acting inhaled …

… , 5 to reduce the need for rescue bronchodilators, 6 and to improve … , inhaled corticosteroid
therapy should also decrease the risk of subsequent ED visits. However, the use of inhaled …

… Inhaled corticosteroids (ICS), when used in combination with long-acting bronchodilators,
reduce the risk … Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-…

… The two major classes of inhaled bronchodilators are beta2-… chamber of the eye. The extent
to which anticholinergic … and mortality risks associated with anticholinergic bronchodilators is …

… effectiveness of long-acting bronchodilators in subjects without an … However, treatment for
ocular hypertension was only required in … . Inhaled corticosteroids and the risk of mortality and …

… corticosteroids was observed in our study population in both frequent and infrequent users
of inhaled bronchodilators and could not explain the different outcomes. Undertreatment is …